Currently Malcolm is Executive Chairman of Hesira Group Limited which he launched in 2013 as a pan-European dental clinics consolidator with investment sponsorship from Oaktree Capital Management LLC. Through an M&A strategy he has built the company to €150m turnover from 80 locally branded clinics in Holland and Switzerland. He is also Non-Executive Chairman and co-founder of BXTAccelyon Limited, a company backed by Elysian Capital LLP which supplies low dose rate brachytherapy treatments for prostate cancer to hospitals worldwide. Previously Malcolm was Chairman of Synexus Clinical Research Plc, an AIM-listed provider of clinical trials services to global pharma and leading CROs and he led the sale of the company to Lyceum Capital LLP in 2007. He is the ex-CEO of Oasis Healthcare Plc (2000-2004) who led the company’s IPO and built the UK dental chain to 130 clinics. Malcolm has also acted as advisor on healthcare investment opportunities for numerous private equity firms.